Ocugen, Inc. (OCGN) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
OCGN Revenue Growth
OCGN Revenue Analysis (2014–2025)
As of May 8, 2026, Ocugen, Inc. (OCGN) generated trailing twelve-month (TTM) revenue of $4.4 million, reflecting significant decline in growth of -125.3% year-over-year. The most recent quarter (Q4 2025) recorded $-193,000 in revenue, down 111.0% sequentially.
Looking at the longer-term picture, OCGN's 5-year compound annual growth rate (CAGR) stands at +152.5%, indicating outstanding long-term growth trajectory. The company achieved its highest annual revenue of $6.0 million in 2023.
When compared to Healthcare sector peers including BEAM (+108.0% YoY), NTLA (+16.9% YoY), and CRSP (-88.9% YoY), OCGN has underperformed the peer group in terms of revenue growth. Compare OCGN vs BEAM →
OCGN Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| $4M | -125.3% | +152.5% | -1425.7% | ||
| $140M | +108.0% | +466.3% | -274.6% | ||
| $68M | +16.9% | +3.1% | -651.7% | ||
| $4M | -88.9% | +37.3% | -16191.4% |
OCGN Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $4.4M | +8.8% | $2.0M | 45.9% | $-62,916,000 | -1425.7% |
| 2024 | $4.1M | -32.8% | $2.1M | 51.5% | $-54,757,000 | -1350.4% |
| 2023 | $6.0M | +142.6% | $5.3M | 88.3% | $-65,531,000 | -1085.7% |
| 2022 | $2.5M | - | $2.5M | 100.0% | $-89,071,000 | -3580.0% |
| 2021 | $0 | -100.0% | $0 | - | $-58,028,000 | - |
| 2020 | $43K | - | $-6,311,000 | -14676.7% | $-21,285,000 | -49500.0% |
| 2019 | $0 | - | $-8,086,000 | - | $-14,163,000 | - |
| 2018 | $0 | - | $-49,623 | - | $-30,108,000 | - |
| 2017 | $0 | - | $-1,534,000 | - | $-24,950,000 | - |
| 2016 | $0 | - | $-1,673,000 | - | $-30,307,000 | - |
See OCGN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs OCGN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare OCGN vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonOCGN — Frequently Asked Questions
Quick answers to the most common questions about buying OCGN stock.
Is OCGN's revenue growth accelerating or slowing?
OCGN revenue declined -125.3% year-over-year, contrasting with the 5-year CAGR of +152.5%. TTM revenue fell to $4M. This reverses the prior growth trend.
What is OCGN's long-term revenue growth rate?
Ocugen, Inc.'s 5-year revenue CAGR of +152.5% reflects the variable expansion pattern. Current YoY growth of -125.3% is below this long-term average.
How is OCGN's revenue distributed by segment?
OCGN reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.